I-Corps: Connected digital health platform with integrated delivery model to improve patient adherence to health goals using insights from data science and behavioral science

这个i-Corps项目的更广泛的影响/商业潜力是帮助糖尿病前期患者使用和坚持糖尿病预防措施，以避免糖尿病的全面发作。8600万美国人是糖尿病前期，有患2型糖尿病的风险，费用为2.3T美元。循证研究已经产生了一项名为糖尿病预防计划(DPP)的协议，由糖尿病教练传授，并由保险覆盖。但对民进党的使用率/依从性很低。10名患者中有9名没有意识到。项目未得到充分利用，患者退出，教练因不遵守规定而得不到保险支付。公司的S技术解决方案将使用数据和行为科学来提高DPP的使用率和忠诚度。这一解决方案使医生、糖尿病教练和患者能够共同提高长期自我护理能力。通过识别糖尿病的风险并将有风险的患者联系到计划中，该公司提高了使用率。通过帮助患者遵守计划，该公司帮助计划遵守并获得报酬。该公司将通过帮助程序创收来收取软件即服务(SaaS)费用。该公司将通过CDC/Medicare设定的明确目标证明其在糖尿病预防市场的价值主张，并利用这一证据向糖尿病以外的其他市场进军。这个i-Corps项目是一个互联的数字健康平台，集成了交付，利用数据科学和行为科学的见解提高患者对健康目标的忠诚度。它包括为医疗服务提供者提供的网络仪表板和为患者提供的同步移动应用程序。通过汇总和学习数十年来在行为科学、机器学习和医学坚持方面的研究，并将其与最近出现的联网技术和计算能力相结合，该公司正在开发一种更好的方法，帮助患者坚持他们的长期健康目标。随着智能手机使用率达到77%(皮尤研究中心，2018)，现在更容易自动和连续地收集数据，进行虚拟干预、支持和跟踪患者。该公司正在利用其团队-S-75年以上在医疗保健、技术、行为心理学和创业方面的经验来应对这一挑战。该公司将通过可穿戴设备和互联技术来简化数据收集和管理。该公司将使用这些患者生成的数据来开发新的预测算法，并将数据可视化，为患者和医疗保健提供者提供见解。此外，该公司将实施行为科学方法和工具，如游戏化和轻推，以加强健康的行为。这一奖项反映了NSF的法定使命，并通过使用基金会的智力优势和更广泛的影响审查标准进行评估，被认为值得支持。

The broader impact/commercial potential of this I-Corps project is to help pre-diabetics use and adhere to diabetes prevention measures to avoid a full-blown episode of diabetes. 86 million Americans are pre-diabetic with risk for developing type 2 diabetes and a cost of $2.3T. Evidence-based research has resulted in a protocol called diabetes prevention program (DPP), taught by diabetes coaches and covered by insurance. But usage/adherence to DPP is low. 9 out of 10 patients are unaware. Programs are underutilized, patients drop off and coaches are not paid by insurance due to non-compliance.The company?s technology solution will use data and behavioral science to improve usage and adherence for DPP. This solution empowers doctors, diabetes coaches and patients to collectively improve long term self-care. By identifying risk of diabetes and connecting at-risk patients to programs, the company improves usage. By helping patients adhere to programs, the company helps programs comply and get paid. The company will collect software as a service (SaaS) fee from programs by helping them with revenue generation. The company will prove its value proposition in the diabetes prevention market with well-defined goals set by CDC/Medicare and use this evidence to move to other markets beyond diabetes. This I-Corps project is a connected digital health platform with integrated delivery to improve patient adherence to health goals using insights from data science and behavioral science. It comprises of a web dashboard for health providers and a synced mobile app for patients. By aggregating and learning from decades of research in behavioral science, machine learning and medical adherence and combining it with connected technologies and computational power that have recently become available, the company is developing a better way to help patients adhere to their long term health goals. With smartphone usage at 77% (Pew Research, 2018), it is now easier to collect data automatically and continuously, intervene, support and track patients virtually. The company is leveraging its team?s 75+ years of combined experience in healthcare, technology, behavioral psychology and entrepreneurship to tackle this challenge. The company will streamline data collection and management through wearables and connected technologies. The company will use this patient generated data to develop new predictive algorithms and visualize data to offer insights to patients and healthcare providers. Additionally, the company will implement behavioral science methodologies and tools such as gamification and nudging to reinforce healthy behaviors.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.